Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Igm Biosciences Inc (NQ: IGMS )

8.350 +0.340 (+4.24%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 323,316
Open 8.050
Bid (Size) 8.010 (1)
Ask (Size) 8.650 (1)
Prev. Close 8.010
Today's Range 8.020 - 8.560
52wk Range 6.450 - 28.20
Shares Outstanding 25,905,471
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Analyst Ratings for IGM Biosciences
Via Benzinga
IGM Biosciences to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
From IGM Biosciences, Inc.
Via GlobeNewswire

Performance

YTD
-50.74%
-50.74%
1 Month
+16.78%
+16.78%
3 Month
-9.63%
-9.63%
6 Month
-40.36%
-40.36%
1 Year
-63.28%
-63.28%

More News

Read More
The Latest Analyst Ratings for IGM Biosciences
Via Benzinga
IGM Biosciences Announces Second Quarter 2023 Financial Results
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Announces Closing of Upsized Public Offering and Concurrent Private Placement and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
From IGM Biosciences, Inc.
Via GlobeNewswire
The Latest Analyst Ratings for IGM Biosciences
Via Benzinga
Analyst Expectations for IGM Biosciences's Future
Via Benzinga
Tech-Heavy Nasdaq Firmly Higher Midday
Via Talk Markets
Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Steelcase, Commercial Metals And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Recap: IGM Biosciences Q1 Earnings
Via Benzinga
Why IGM Biosciences (IGMS) Stock Is Trading Higher
Via Benzinga
US Stocks Lower Following Initial Jobless Claims Report
Via Benzinga
IGM Announces Pricing of $107.3 Million Upsized Public Offering and Concurrent Private Placement
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Announces Proposed Public Offering and Concurrent Private Placement
From IGM Biosciences, Inc.
Via GlobeNewswire
Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
EPAM Systems, Amyris, Blueprint Medicines And Other Big Stocks Moving Lower On Monday
Via Benzinga
IGM Biosciences Announces Update on IGM-8444 Phase 1 Trial and Future Clinical Development
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Biosciences to Present at the Jefferies Healthcare Conference
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Biosciences Announces FDA Clearance to Begin Clinical Studies of Imvotamab in Lupus and Rheumatoid Arthritis
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Biosciences to Host Conference Call and Webcast to Provide IGM-8444 Clinical Update
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Biosciences Announces First Quarter 2023 Financial Results and Provides Corporate Update
From IGM Biosciences, Inc.
Via GlobeNewswire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
IGM Biosciences to Present at Two Upcoming Investor Conferences
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Biosciences to Present at the Stifel 2023 Targeted Oncology Days
From IGM Biosciences, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.